Description
Generic Version of Trastuzumab Available in India?
Trastuzumab is the salt name for the drug sold under the brand name Priunta. It is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer. It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).
Trastuzumab injection is also used in combination with cisplatin and capecitabine or 5-fluorouracil to treat HER2-overexpressing metastatic (cancer that has spread) stomach and gastroesophageal (stomach and esophagus) cancer.
Trastuzumab prevents the growth of some tumors that produce extra amounts of a certain substance known as the HER2 protein. It should only be used in patients whose tumors have been shown to produce extra amounts of this protein (HER2 overexpression).
Will this product be accessible across all regions of India?
The product – Priunta (Trastuzumab) Injection will be available across India on request. Trastuzumab is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
List of available brand-name drugs in India for Trastuzumab Injection
Branded Generic Drugs for Trastuzumab Injection: Biceltis | Canmab | Eleftha | Herclon | Hermab | Hersima Hertraz | Hervycta | Trasturel | Trazumab | Trumab | Ujvira
NEWS / UPDATES
- Aurobindo Pharma secures marketing authorisation for Trastuzumab biosimilar in India.
- AstraZeneca India receives CDSCO approval for sale, distribution of Trastuzumab.
- Trastuzumab Biosimilar, Hervycta, Launches in India.
- India’s first US FDA approved Biosimilar Trastuzumab brings new hope to patients.
- Generic Herceptin Approved in India.
- Roche-Launches-2-In-1-Biotech-Drug-For-Breast-Cancer-In-India.
- Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India.
- Roche Pharma launches PHESGO in India for the treatment of HER-2 positive breast .






